VICTORIA MARTZ: Open Payments
NPI 1992429831 · KETTERING, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$493 in 23 payments from 14 companies in 2025. Trend: 2023 $517 · 2024 $351 · 2025 $493
Food & beverage: $458Education: $35
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $120 |
| AKEBIA THERAPEUTICS INC | 1 | $83 |
| Fresenius USA Marketing, Inc. | 2 | $41 |
| Otsuka America Pharmaceutical, Inc. | 2 | $37 |
| OPKO Pharmaceuticals, LLC | 2 | $35 |
| SCPHARMACEUTICALS INC. | 2 | $33 |
| Ardelyx, Inc. | 1 | $28 |
| Novo Nordisk Inc | 1 | $24 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $19 |
| GlaxoSmithKline, LLC. | 1 | $18 |
Products named: Kerendia, Vafseo, VELPHORO, RAYALDEE, FUROSCIX, IBSRELA, Wegovy, JYNARQUE.
Industry payments across OH — which companies pay providers there.
